This Article Full Text Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Carmena, R. Articles by Davignon, J. Search for Related Content PubMed PubMed Citation Articles by Carmena, R. Articles by Davignon, J.

(Arteriosclerosis, Thrombosis, and Vascular Biology. 1996;16:129-136.)
© 1996 American Heart Association, Inc.

Articles

Lp(a) Levels and Atherosclerotic Vascular Disease in a Sample of Patients With Familial Hypercholesterolemia Sharing the Same Gene Defect

Rafael Carmena; Suzanne Lussier-Cacan; Madeleine Roy; Anne Minnich; Arno Lingenhel; Florian Kronenberg; Jean Davignon

From the Endocrine Service, Hospital Clinico Universitario, Valencia, Spain (R.C.); the Hyperlipidemia and Atherosclerosis Research Group, Clinical Research Institute of Montreal, Quebec, Canada (S.L.-C., M.R., A.M., J.D.); and the Institute for Medical Biology and Genetics, University of Innsbruck, Innsbruck, Austria (A.L., F.K.).

Correspondence to Dr S. Lussier-Cacan, Clinical Research Institute of Montreal, 110 Pine Ave W, Montreal, Quebec, Canada H2W 1R7. E-mail cacans@ircm.umontreal.ca.

Abstract There is considerable variation in the severity of cardiovascular disease among patients with familial hypercholesterolemia (FH). Some reports have suggested that plasma lipoprotein(a) [Lp(a)] levels may explain such variation and that FH subjects deficient in LDL receptors, especially those with coronary heart disease, tend to have elevated Lp(a) levels. We have investigated the possible role of the LDL receptor in determining plasma Lp(a) levels in a genetically homogeneous FH population and the contribution of Lp(a) to cardiovascular risk. A total of 98 FH subjects and 66 healthy first- and second-degree relatives from 30 families with FH due to the French-Canadian >10-kilobase deletion of the LDL receptor gene were studied. A reference group of 392 normolipidemic French-Canadian participants in a Heart Health Survey was used for comparison. FH subjects were subdivided into subsets of 63 individuals free from atherosclerotic vascular disease (AVD) and 35 individuals with AVD. A complete cardiovascular evaluation was performed, and plasma lipid, lipoprotein, and Lp(a) levels were measured in all subjects in the absence of medication. Apolipoprotein (a) [apo(a)] phenotype was determined in 112 of FH and non-FH subjects. The log-transformed values for plasma Lp(a) were not significantly different among the three groups: 0.98±0.54 (mean±SD) in FH subjects with AVD, 0.89±0.51 in FH subjects without AVD, and 0.82±0.64 in their relatives. The distribution of the apo(a) phenotypes did not differ between the FH and non-FH groups. Comparison of two age- and sex-matched subgroups of FH subjects, with and without AVD, failed to show any differences in Lp(a) level. However, mean Lp(a) log values in the reference group (n=392) were significantly lower than values obtained for the total FH group (0.79±0.57 versus 0.92±0.52, respectively; P<.05) but were not different from those of the unaffected family members. Thus, in our sample, the LDL receptor appears not to influence plasma Lp(a) levels; rather, these levels reflect shared apo(a) genes. The cardiovascular risk in this group of subjects with FH was related to age, male sex, total and LDL cholesterol, and higher apoB but not Lp(a) levels.

Key Words: familial hypercholesterolemia lipoprotein(a) • atherosclerotic complications

This article has been cited by other articles:

				D. T. Holmes, B. A. Schick, K. H. Humphries, and J. Frohlich Lipoprotein(a) Is an Independent Risk Factor for Cardiovascular Disease in Heterozygous Familial Hypercholesterolemia Clin. Chem., November 1, 2005; 51(11): 2067 - 2073. [Abstract] [Full Text] [PDF]

				S. Gonbert, B. Saint-Jore, P. Giral, C. Doucet, J. Chapman, and J. Thillet Molecular Analysis of Apo(a) Fragmentation in Polygenic Hypercholesterolemia: Characterization of a New Plasma Fragment Pattern Arterioscler. Thromb. Vasc. Biol., August 1, 2001; 21(8): 1353 - 1358. [Abstract] [Full Text] [PDF]

				J.T Real, F.J Chaves, I Martinez-Uso, A.B Garcia-Garcia, J.F Ascaso, and R Carmena Importance of HDL cholesterol levels and the total/ HDL cholesterol ratio as a risk factor for coronary heart disease in molecularly defined heterozygous familial hypercholesterolaemia Eur. Heart J., March 2, 2001; 22(6): 465 - 471. [Abstract] [PDF]

				H. G. Kraft, A. Lingenhel, F. J. Raal, M. Hohenegger, and G. Utermann Lipoprotein(a) in Homozygous Familial Hypercholesterolemia Arterioscler. Thromb. Vasc. Biol., February 1, 2000; 20(2): 522 - 528. [Abstract] [Full Text] [PDF]

				M. E. Wittekoek, S. N. Pimstone, P. W. A. Reymer, L. Feuth, G.-J. Botma, J. C. Defesche, M. Prins, M. R. Hayden, and J. J. P. Kastelein A Common Mutation in the Lipoprotein Lipase Gene (N291S) Alters the Lipoprotein Phenotype and Risk for Cardiovascular Disease in Patients With Familial Hypercholesterolemia Circulation, March 3, 1998; 97(8): 729 - 735. [Abstract] [Full Text] [PDF]

				A. F. Vuorio, H. Turtola, K.-M. Piilahti, P. Repo, T. Kanninen, and K. Kontula Familial Hypercholesterolemia in the Finnish North Karelia : A Molecular, Clinical, and Genealogical Study Arterioscler. Thromb. Vasc. Biol., November 1, 1997; 17(11): 3127 - 3138. [Abstract] [Full Text]

				R. A. Hegele, W. C. Breckenridge, J. H. Brunt, and P. W. Connelly Genetic Variation in Factor VII Associated with Variation in Plasma Lipoprotein(a) Concentration Arterioscler. Thromb. Vasc. Biol., September 1, 1997; 17(9): 1701 - 1706. [Abstract] [Full Text]